The original success of Viagra has created a tangled shadow over the wider pharmaceutical landscape. While the maker initially reaped substantial revenue, competing versions now diminish its market share , presenting challenges for stakeholders considering positions in affected companies. Doubts about the sustained viability of ED medication income

The emergence of so-called "High Roller Sildenafil" – often referring to exceptionally high doses ordered by rogue physicians – represents a particularly alarming trend. While typical dosages of Sildenafil are intended for treating erectile dysfunction safely in most individuals, these significantly elevated quantities pose a significant risk t